XS2406607171 · Corp · EUR

Teva Pharmaceutical Finance Nether 4.38% 2030/05

MID PRICE
118.61
par = 100
YIELD TO MAT.
4.20%
semi-annual
COUPON
4.380%
semi-annual · fixed
MATURITY
2030-05-09
bullet · 4.01y
OUTSTANDING
not disclosed
AS OF
2026-05-01
Fund disclosure

Sign up free to see prices on this bond

Free accounts get 40 bond price views per month — 4× the anonymous quota. Pro is unlimited.

Risk analytics

SEMI-ANNUAL · BULLET · PAR 100
Modified duration
3.57 y
1bp ↑ ≈ -0.036% P&L
Convexity
15.40
higher = more curvature
Years to maturity
4.01 y
YTM source
Ingested
Fund disclosure
G-spread
+147 bps
vs ECB AAA curve · 2026-04-29
Market signals · funds disclosing this bond
SignalCategoryExposureLast moveWeightAs of
iShares Global High Yield Corporate Bond
iShares
Global HY Corporate$182K▲ $5920.09%2026-05-01
Subscribe to reveal which signals are holding this bond.Subscribe →

Price history

Sherpa Signal

AS OF 2026-05-01

Institutional footprint · signal-level holdings

0/ 100
Interpretation. Thin coverage — below signal threshold
HOLDERS
1
unchanged in 7d
AGGREGATE EXPOSURE
$182K
USD across all
TOP CONCENTRATION
100.0%
largest holder
FLOW
unchanged in 7d

Sherpa Signal is derived from a panel of tracked institutional portfolios. Names of individual holders are not disclosed.

100K PAR NOTIONAL · MARKET VALUE
118,610 EUR
138,798 USD
FX SOURCE
ECB · CoinGecko
PRICE
118.61

RFQ routing · coming soon

Security details

VIA OPENFIGI
Canonical
TEVA 4 3/8 05/09/30
FIGI
BBG0136TNQ18
ISIN
XS2406607171
Type
Corp
Issued
2021-11-09
Face value
100 EUR
Ticker
TEVA 4.375 05/09/30
Sec. type
GLOBAL
Seniority
Senior Unsecured

Issuer curve

TEVA · 10 PTS

Yield (%) plotted against years-to-maturity. This bond highlighted in amber.